Intriguingly, sCD163 secretion by PBMCs ex vivo may serve as a biomarker of SSc progression, as increased production of sCD163 by PBMCs was associated with worse prognosis of SSc (233). The gene discussed is CD163; the disease is systemic sclerosis.